Today's Rundown Featured Story | | | Tuesday, July 9, 2019 BioNTech has raised $325 million (€289 million) in a private fundraising round. The series B positions the immuno-oncology player to advance its multidrug clinical pipeline and grow its manufacturing footprint. |
|
|
| This week's sponsor is Medrio. | |  | [Webinar] Accelerating Site and Patient Enrollment for Phase 1 Trials
Tuesday, July 23 | 2pm ET / 11am PT
This Fierce webinar will feature clinical trial site leaders and R&D executives, who will pass along the latest strategies for boosting site and patient enrollment in phase 1 trials. They will discuss best practices for communicating with both investigators and patients. Register Now! |
Top Stories Tuesday, July 9, 2019 China is a big area of opportunity for biotech: a population of about 1.4 billion with a sizable and growing chunk of that demographic succumbing to chronic, middle-class diseases like diabetes, cancer and heart disease. Tuesday, July 9, 2019 IGM Biotherapeutics picked up $102 million in series C financing to work on its pipeline of cancer drugs, including a CD20- and CD3-targeting bispecific antibody slated to start clinical trials by the end of the year. Tuesday, July 9, 2019 Celsius’ new partnership with Janssen Biotech is a win-win situation—it will feed Celsius' drug discovery and help Janssen work on a treatment for inflammatory bowel disease. Tuesday, July 9, 2019 Celgene has expanded its deal with Nimbus Therapeutics to secure an option on an HPK1 inhibitor program. Nimbus will take the drug up to a clinical inflection point, at which time Celgene will choose whether to take up its option. Monday, July 1, 2019 It’s the summer and that means one thing in the FierceBiotech office: it’s time of year when we want your nominations for this year’s fiercest private biotech companies. Every year we want to see the brightest and the best that young biotechs have to offer. Monday, July 8, 2019 Arming the immune system so it can recognize and attack solid tumors has proven to be an illusive goal. Scientists at Columbia University hope to change that with an engineered form of the bacterium E. coli that's designed to colonize solid tumors. In mouse models, the treatment cleared primary tumors and reduced metastasis. | This week's sponsor is ExL Events. | |  | |
Resources Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: United Cargo and SAVSU Technologies The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Patheon, by Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Patheon, by Thermo Fisher Scientific Anticipate challenges in formulation early. Sponsored by: Titian Software This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software. Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
.jpg/BioNTech_Headquarters%20(1).jpg/b67ef2820c39e3890b54e5955e1eb3bb)